» Articles » PMID: 31354322

Obesity, Adipocyte Hypertrophy, Fasting Glucose, and Resistin Are Potential Contributors to Nonalcoholic Fatty Liver Disease in South Asian Women

Overview
Publisher Dove Medical Press
Specialty Endocrinology
Date 2019 Jul 30
PMID 31354322
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Nonalcoholic fatty liver disease (NAFLD) is often referred to as the hepatic manifestation of the metabolic syndrome. The relationship between body weight, NAFLD, and insulin resistance is not well characterized in humans. Additionally, it is unclear why South Asians develop these complications at lower levels of obesity compared to their Western counterparts. To address this question, we performed a cross-sectional study using a convenience sample of Sri Lankan adult females (n=34) and collected anthropometric data, adipose tissue specimens (for histology), and fasted serum samples (for metabolic and inflammatory markers). Hepatic steatosis was assessed by ultrasound scanning and used to classify participants as NAFL 0, NAFL 1, and NAFL 2. Waist circumference significantly increased with increasing NAFL grade. Participants with NAFL had significantly higher body mass index, hip circumference, and fasting plasma glucose, as well as a higher mean adipocyte area in both abdominal subcutaneous and visceral areas, indicating a higher degree of adipocyte hypertrophy associated with fatty liver. There were, however, no differences in measures of dyslipidemia. Of the multiple adipokines measured, resistin was the only proinflammatory adipokine significantly elevated in NAFL 2. These findings indicate that measures of adiposity, fasting serum glucose, and resistin may be important indicators of NAFLD in South Asian women.

Citing Articles

Forns index and fatty liver index, but not FIB-4, are associated with indices of glycaemia, pre-diabetes and type 2 diabetes: analysis of The Maastricht Study.

Heyens L, Kenjic H, Dagnelie P, Schalkwijk C, Stehouwer C, Meex S BMJ Open Gastroenterol. 2024; 11(1).

PMID: 39615896 PMC: 11624825. DOI: 10.1136/bmjgast-2024-001466.


Efficacy of Adding Sitagliptin to Ongoing Metformin on Metabolic Profile, Triglyceride-Glucose Index, Vitamin D3, and Liver Tests in Patients Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease: A Double-Blind Randomized Clinical Trial.

Yaribeygi H, Ramezani M, Katsiki N, Mirmohammadkhani M, Tabaei N Curr Ther Res Clin Exp. 2024; 101:100764.

PMID: 39582742 PMC: 11584711. DOI: 10.1016/j.curtheres.2024.100764.


The Beneficial Additive Effect of Silymarin in Metformin Therapy of Liver Steatosis in a Pre-Diabetic Model.

Huttl M, Markova I, Miklankova D, Zapletalova I, Poruba M, Racova Z Pharmaceutics. 2022; 14(1).

PMID: 35056941 PMC: 8780287. DOI: 10.3390/pharmaceutics14010045.


Managing cardiovascular disease risk in South Asian kidney transplant recipients.

Prasad G, Bhamidi V World J Transplant. 2021; 11(6):147-160.

PMID: 34164291 PMC: 8218347. DOI: 10.5500/wjt.v11.i6.147.


Tuina for diabetes with obesity: Protocol for a systematic review and meta-analysis.

Peng S, Xie Z, Zhang X, Liu Y, Zhang X, Liang X Medicine (Baltimore). 2021; 100(3):e23918.

PMID: 33545962 PMC: 7837875. DOI: 10.1097/MD.0000000000023918.


References
1.
Deurenberg-Yap M, Schmidt G, van Staveren W, Deurenberg P . The paradox of low body mass index and high body fat percentage among Chinese, Malays and Indians in Singapore. Int J Obes Relat Metab Disord. 2000; 24(8):1011-7. DOI: 10.1038/sj.ijo.0801353. View

2.
Steppan C, Bailey S, Bhat S, Brown E, Banerjee R, Wright C . The hormone resistin links obesity to diabetes. Nature. 2001; 409(6818):307-12. DOI: 10.1038/35053000. View

3.
Chitturi S, Farrell G . Etiopathogenesis of nonalcoholic steatohepatitis. Semin Liver Dis. 2001; 21(1):27-41. DOI: 10.1055/s-2001-12927. View

4.
Forouhi N, Sattar N, McKeigue P . Relation of C-reactive protein to body fat distribution and features of the metabolic syndrome in Europeans and South Asians. Int J Obes Relat Metab Disord. 2001; 25(9):1327-31. DOI: 10.1038/sj.ijo.0801723. View

5.
Youssef W, McCullough A . Diabetes mellitus, obesity, and hepatic steatosis. Semin Gastrointest Dis. 2002; 13(1):17-30. View